ZURA BIO LTD (ZURA)
KYG9TY5A1016 - Common Stock
Which stocks are moving after the closing bell on Tuesday?
As the regular session of the US market concludes on Tuesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Zura Bio to Present at the Piper Sandler 36th Annual Healthcare Conference
Zura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate Updates
Zura Bio to Participate in Two Upcoming Investor Conferences in November
Zura Bio to Present at Three Upcoming Investor Conferences in September
ZURA Stock Earnings: Zura Bio Misses EPS for Q2 2024
ZURA stock results show that Zura Bio missed analyst estimates for earnings per share the second quarter of 2024.
ZURA Stock Earnings: Zura Bio Misses EPS for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Zura Bio (NASDAQ:ZURA) just reported results for the second quarter of 2024.Zur...
Zura Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights
Zura Bio Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to its Warrants
Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors
3 Undervalued Biotech Stocks With Breakout Potential
Invest in these three undervalued biotech stocks with double-digit upside ahead driven by cutting-edge healthcare advancements
Zura Bio Commences Warrant Exchange Offer and Consent Solicitation
The 3 Most Undervalued Biotech Stocks to Buy in July 2024
There’s always a strong case for undervalued biotech stocks especially with newer innovation and demand for better treatment.
Zura Bio Presents Data for the Tibulizumab (ZB-106) Program at EULAR 2024
Zura Bio Forms Scientific Advisory Board with Prominent Specialists in Rheumatology, Dermatology, and Immunology
Zura Bio Announces Participation in June Investor Conferences
3 Penny Stocks to Buy Now: May 2024
Penny stocks to buy carry a considerable amount of risk and extra sue dilligence is required before buying shares.
ZURA Stock Earnings: Zura Bio Beats EPS for Q2 2024
ZURA stock results show that Zura Bio beat analyst estimates for earnings per share the second quarter of 2024.
Zura Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights
Zura Bio Announces Oversubscribed $112.5 Million Private Placement
Zura Bio Announces Robert Lisicki as CEO and Director
Redx to Quit London Stock Exchange’s AIM, Citing Low Liquidity
Biotech company Redx Pharma Plc is set to pull its shares from the London Stock Exchange’s smallest market, citing liquidity constraints and saying it will attract investors more easily as a private company.
ZURA Stock Earnings: Zura Bio Misses EPS for Q4 2023
ZURA stock results show that Zura Bio missed analyst estimates for earnings per share the fourth quarter of 2023.
ZURA Stock Earnings: Zura Bio Misses EPS for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Zura Bio (NASDAQ:ZURA) just reported results for the fourth quarter of 2023.Zur...
Zura Bio Announces Participation at March Conferences
Zura Bio Announces Participation at February Investor Conferences
Zura Bio appoints industry veteran Robert Lisicki as President and COO (NASDAQ:ZURA)
Zura Bio (NASDAQ:ZURA) has appointed Robert Lisicki as President and Chief Operating Officer.Mr.
Zura Bio Continues to Strengthen Leadership with Appointment of Robert Lisicki as President and Kiran Nistala as CMO
Zura Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Dermatology Summit
Zura Bio Announces Two Immunology Abstracts Presented at the World Allergy Congress in Bangkok
Relative Strength Alert For Zura Bio
Zura Bio Appoints Arnout Ploos van Amstel to its Board of Directors
